Heart disease develops differently in women and men. Women respond better to cardiac resynchronization therapy, but many women aren't treated.
A new drug shows promise in improving the treatment of heart failure. A clinical trial showed it lowered the chances of death or hospitalization by about 20 percent compared to the current standard drug treatment.
“Star Trek: The Next Generation’s” Jean Luc Picard had an artificial heart. But the 21st century version is even better than its imaginary counterpart.
Transplanting human hearts is becoming less necessary as a new generation of implantable mechanical heart assist devices comes online. Led by Cleveland Clinic researchers, this movement will the biggest transformation for human hearts since transplantation made them modular in 1967.
Implantable cardioverter defibrillators (ICDs) prevent sudden death when damaged hearts develop dangerous arrhythmias. They improve survival even if your heart has little damage, a new study confirms.
Cardiac rehab improves quality of life for heart patients and may save lives, but until now, those with heart failure who rely on Medicare were out of luck. Reversing a 2009 denial of benefits, CMS now supports coverage.
Heart failure shouldn't keep you from exercising. In a boundary-expanding study, researchers found that vigorous exercise benefits some patients with heart failure more than low intensity workouts.
The headlines cause gasps of disbelief: A star high school or college athlete suddenly collapses and dies after a workout or a game. The culprit in many cases is hypertrophic cardiomyopathy (HCM). Here's why.
Mechanical heart pumps, or left ventricular assist devices (LVADs), are lifesaving devices for patients with advanced heart failure, but a new study shows that the HeartMate II has higher risk than originally believed.
The drug serelaxin is on track to become the first treatment breakthrough for acute heart failure in two decades.